Covestor LTD Prometheus Biosciences, Inc. Transaction History

Covestor LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$103.46 - $126.29 $7,138 - $8,714	69 Added 2300.0%	72 $8,000
Q4 2022 Feb 13, 2023	SELL	$36.06 - $117.21 $108 - $351	-3 Reduced 50.0%	3 $0
Q3 2022 Nov 14, 2022	SELL	$28.17 - $59.01 $28 - $59	-1 Reduced 14.29%	6 $0
Q2 2022 Aug 10, 2022	SELL	$22.39 - $38.94 $44 - $77	-2 Reduced 22.22%	7 $0
Q1 2022 May 13, 2022	BUY	$30.13 - $50.0 $271 - $450	9 New	9 $0

29.6K

Ticker RXDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,904,100
Description
Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial...

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

Stay updated on Covestor LTD with notifications on news.